HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mario H Skiadopoulos Selected Research

Anthrax Vaccines (Vaccines, Anthrax)

1/2021Efficacy of the AV7909 anthrax vaccine candidate in guinea pigs and nonhuman primates following two immunizations two weeks apart.
1/2020Development of a guinea pig inhalational anthrax model for evaluation of post-exposure prophylaxis efficacy of anthrax vaccines.
1/2017Correlation between anthrax lethal toxin neutralizing antibody levels and survival in guinea pigs and nonhuman primates vaccinated with the AV7909 anthrax vaccine candidate.
12/2016Licensure strategy for pre- and post-exposure prophylaxis of biothrax vaccine: the first vaccine licensed using the FDA animal rule.
11/2013Effect of anthrax immune globulin on response to BioThrax (anthrax vaccine adsorbed) in New Zealand white rabbits.
11/2013Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.
4/2013Pathology and pathophysiology of inhalational anthrax in a guinea pig model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mario H Skiadopoulos Research Topics

Disease

8Anthrax
01/2021 - 04/2013
4Paramyxoviridae Infections (Parainfluenza)
04/2007 - 12/2002
4Respiratory Tract Diseases (Respiratory Tract Disease)
12/2004 - 12/2002
3Virus Diseases (Viral Diseases)
03/2006 - 05/2002
2Human Influenza (Influenza)
01/2021 - 12/2002
2Toxemia
07/2014 - 11/2013
2Infections
08/2008 - 10/2005
1Body Weight (Weight, Body)
11/2013
1Inhalation anthrax
11/2013
1Edema (Dropsy)
04/2013
1Hemorrhage
04/2013
1Inflammation (Inflammations)
04/2013
1Necrosis
04/2013
1Dengue (Dengue Fever)
12/2002
1Measles
12/2002

Drug/Important Bio-Agent (IBA)

11VaccinesIBA
01/2021 - 05/2002
7Anthrax Vaccines (Vaccines, Anthrax)IBA
01/2021 - 04/2013
4AntigensIBA
01/2021 - 05/2002
3Neutralizing AntibodiesIBA
01/2021 - 11/2013
3Proteins (Proteins, Gene)FDA Link
08/2008 - 10/2005
2BiothraxIBA
11/2013 - 11/2013
2Anthrax Immune Globulin IntravenousIBA
11/2013 - 11/2013
2Immunoglobulins (Immunoglobulin)IBA
11/2013 - 11/2013
2Interferon Type IIBA
08/2008 - 03/2006
1anthrax toxin (anthrax lethal factor)IBA
01/2021
1Hemagglutinins (Hemagglutinin)IBA
01/2021
1Influenza Vaccines (Influenza Vaccine)FDA Link
01/2021
1Ciprofloxacin (Cipro)FDA LinkGeneric
01/2020
1ProMune (CpG 7909)IBA
01/2017
1AntitoxinsIBA
07/2014
1Monoclonal AntibodiesIBA
07/2014
1Anti-Bacterial Agents (Antibiotics)IBA
07/2014
1AVP-21D9IBA
07/2014
1Immunoglobulin G (IgG)IBA
11/2013
1AntibodiesIBA
11/2013
1AerosolsIBA
04/2013
1FibrinIBA
04/2013
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2002
1Complementary DNA (cDNA)IBA
12/2002
1Attenuated VaccinesIBA
12/2002
1Synthetic Vaccines (Recombinant Vaccines)IBA
05/2002

Therapy/Procedure

2Therapeutics
01/2020 - 07/2014